TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Peak blood concentration of MRX34
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Area Under the Curve (AUC) of MRX34
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Drug concentration in tissue biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Subjects Whose Plaque Achieves Clear or Almost Clear Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: First postoperative flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sleep recording Reliability
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Incidence of post-discharge nausea and vomiting (PDNV)
Endpoint domain: Adverse events/effects
Primary endpoint: Heart rhythm detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vulvar pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Fatal Outcome
Endpoint domain: Mortality/survival
Primary endpoint: Endothelial Bleb Areas on Cornea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Galactin 3 level in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ADHD symptoms in adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD symptoms in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in WOMAC Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline in Quantitative Synovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline in Effusion Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline in WORMS Semi-Quantitative Synovitis/Effusion Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cmax of BAY1834942 after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-504) of BAY1834942 after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Residual Disease (MRD) Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with delayed Post-Polypectomy Induced Ulcer (PPIU) bleeds
Endpoint domain: Adverse events/effects
Primary endpoint: Safety-reported MACE
Endpoint domain: Adverse events/effects
Primary endpoint: prognosis or outcome of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Objective Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core symptoms of AN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of LAH in ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of 18F-DOPA PET/CT Scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to Complete Treatment Aligners
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: HLA-DR expression level of alveolar monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Marginal Bone Level Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capacity at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of angina pectoris symptoms at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from pre-operative awake EEG measurement to sleep EEG measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in baseline diagnosis of delirium to hospital discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Adverse Events Assessed by CTCAE v4.0
Endpoint domain: Adverse events/effects
Primary endpoint: Number of GELs Newly Appearing at Weeks 4, 12 and 24 After MSC Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amino acid profiles in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease Time of Oral Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antimicrobial peptides expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PCP adherence to chronic opioid therapy guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in level of cystLTs and adenosine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients With CD34+ Cells ≥5.0 x 10^6 Cells/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Graded Standard Systemic Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Fluctuation of HVPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Condition-specific treatment satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increase in FEV1 ≥ 12%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decrease in total SGRQ score ≥ 4 points
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of all-cause admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: preventable admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cognitive reserve
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cumulative incidence of atrial arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Bacterial Microflora on the Inguinal Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Bacterial Microflora on the Abdomen Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Abstinence from opiates and cocaine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area under the plasma concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VWF (von Willebrand factor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in composition of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hospital anxiety and depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incident of intraoperative desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient comfort on high flow nasal cannula
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Atelactasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hypersensitivity to pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in MRS Metabolic Ratio: NAA + NAAG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in MRS Metabolic Ratio: Choline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in MRS Metabolic Ratio: Myoinositol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Neurocognitive Function: Memory T Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in Neurocognitive Function: Attention Scaled Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ischemic composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in volumetric size of internal root resorption lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placental function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Live birth obtained after IVF-ET
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants with diagnosed Atrial Fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parasitemia in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants With Any Serious Adverse Events (SAEs) and Any Non-serious Adverse Events (Non-SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Linear healing rate (LHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best response as measured by Cheson response criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of PDA closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in PDA size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: future remnant liver function (RLF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary intake assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consideration of Regret
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Test Uptake: Number of Clients Who Indicated Intention to Have Genetic Testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decision Self-efficacy: Ability to Confidently Make Decision About Genetic Testing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient Empowerment (Client Completed): Ability to Manage Information and Risk Associated With Hereditary Breast and Ovarian Cancer (HBOC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Verbal Learning Memory Test Long Delayed Recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Insulin adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic accuracy of echocardiography in evaluating myocardial ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite Endpoint of Device Success and Freedom From Device or Procedure Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma GSK1349572 Ctau
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in perceived self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Longitudinal changes in knowledge scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Overall Responder Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for medical treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Long term tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: successful detection of SLN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angular and vertical linear effects on incisors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: angular and vertical linear effects on first molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Vertigo suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of hospitalization or death
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of hospitalization, death or major thrombosis
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of high flow oxygen, mechanical ventilation, or death
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of high flow oxygen, mechanical ventilation, death or major thrombosis
Endpoint domain: Mortality/survival
Primary endpoint: Safety Parameters
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Residual Urine Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall H3 Receptor Occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average spectral amplitude changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Reporting Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Other Adverse Events Leading to Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Adverse Events Leading to Death
Endpoint domain: Adverse events/effects
Primary endpoint: Pericardial Effusion Requiring Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Device Embolization (Major)
Endpoint domain: Adverse events/effects
Primary endpoint: Sternal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of dose limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in length-for-age Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Metrics of ischemia / repercussion injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients with a positive biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of contacts with mental health services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in daily average urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Participants With Complete Response (CR) at 8 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum mouth opening range without pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum mouth opening range with pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SANS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Complete Hematologic Response (CHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: patient's unpleasantness due to the noise
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical reference panel (blood)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinical reference panel (urine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Body Composition (Body Fat)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of ADRB3 receptor in human pregnant myometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: height of augmented bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State of health score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for life-prolonging care
Endpoint domain: Mortality/survival
Primary endpoint: Patterns of resistance including point mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in plasma lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative number of cold days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI BOLD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: brain electrical activity through MEG response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: blood flow and dopaminergic function through PET studies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Insomnia Severity Inventory (ISI) total score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: composite of major adverse clinical events at 30-days post-procedure
Endpoint domain: Mortality/survival
Primary endpoint: composite of major adverse clinical events between 31-days and 12-months post-procedure
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of participants with Treatment Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: changes in absolute lymphocyte counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Survival at 28 Days
Endpoint domain: Mortality/survival
Primary endpoint: Symptom Elimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Solicited adverse events during 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited adverse events during 42 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Efficiency of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: increase in global LV ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total biofilm mass on ureteral stents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of morbidity using the Ureteral Stent Symptom Questionnaire (USSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic accuracy of quantitative MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: risky alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risky drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risky sex behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Investigator's Global Assessment (IGA) Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Loss of Mineral Density in the Enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical pregnancy rate per ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Peak blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the glucose-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Moderate to Severe Postoperative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Visual Analogue Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nipple to Fold Measurement on Stretch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically Significant Dermal Irritation
Endpoint domain: Adverse events/effects
Primary endpoint: time to retreatment with bevacizumab
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of absorption of hesperidin and narirutin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response determined by MRI (modified RANO criteria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LV Lead-related complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of severe acute respiratory syndrome related to coronavirus-2 in brain tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quantification of inflammation, necrosis and hemorrhage in different brain areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of Participants With Mild or no Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Loss of fixation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accumulated physiological stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes